Early-Phase Oral Antiviral Use and Post–COVID-19 Condition in Outpatients - Summary - MDSpire

Early-Phase Oral Antiviral Use and Post–COVID-19 Condition in Outpatients

  • By

  • Makoto Hibino

  • Ayumi Shintani

  • Hiroyuki Murayama

  • Nobuyuki Morikawa

  • Kazunari Maeda

  • Sho Nishiguchi

  • Eiji Monma

  • Hiromasa Harada

  • Tsunekazu Takagi

  • Satoshi Kuroyanagi

  • Kiyoshi Endo

  • Yasushi Terada

  • Masahiro Kinoshita

  • Takahiro Yoden

  • Shogo Miyazawa

  • Shinichi Higashiue

  • May 15, 2026

  • 0 min

Share

Objective:

To evaluate the association of early oral antiviral use with the risk of post–COVID-19 condition (PCC) in outpatient settings during the Omicron era in Japan.

Key Findings:
  • Early antiviral treatment may reduce the risk of PCC by limiting viral replication and inflammation.
  • The study included diverse outpatient populations across Japan, enhancing the generalizability of findings.
  • PCC was assessed based on specific symptoms reported at both day 28 and day 84.
Interpretation:

The findings suggest that early administration of oral antivirals could be beneficial in reducing the incidence of PCC among outpatients, particularly in the context of the Omicron variant.

Limitations:
  • The study's observational design may introduce biases.
  • Data on long-term outcomes beyond 84 days were not collected.
  • The generalizability of results may be limited to the Japanese healthcare context.
Conclusion:

Early oral antiviral treatment may play a crucial role in mitigating the risk of post–COVID-19 syndrome in outpatient settings, warranting further investigation.

Original Source(s)

Early-Phase Oral Antiviral Use and Post–COVID-19 Condition in Outpatients

  • by Makoto Hibino, Ayumi Shintani, Hiroyuki Murayama, Nobuyuki Morikawa, Kazunari Maeda, Sho Nishiguchi, Eiji Monma, Hiromasa Harada, Tsunekazu Takagi, Satoshi Kuroyanagi, Kiyoshi Endo, Yasushi Terada, Masahiro Kinoshita, Takahiro Yoden, Shogo Miyazawa, Shinichi Higashiue

  • May 15, 2026

Related Content

Characterization of post-COVID syndrome by self-perceived symptom severity stratified by infection wave: beyond COVID, a prospective, multicenter cohort study in Germany

Assessing the association of physical distancing to avoid COVID-19 with health-related quality of life in immunocompromised adolescents: results from the cross-sectional observational EAGLE study

COVID-19, Vaccines, and Retinal Vascular Disease

A global systematic review of 173 studies found differing associations between COVID-19 infection and vaccination and retinal vascular events, with retinal artery occlusion more common after infection and retinal vein occlusion more common after vaccination.